{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:25:13Z","timestamp":1761863113203},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,7,11]],"date-time":"2012-07-11T00:00:00Z","timestamp":1341964800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s00726-012-1354-3","type":"journal-article","created":{"date-parts":[[2012,7,10]],"date-time":"2012-07-10T13:29:57Z","timestamp":1341926997000},"page":"461-472","source":"Crossref","is-referenced-by-count":6,"title":["TAT-CC fusion protein depresses the oncogenicity of BCR-ABL in vitro and in vivo through interrupting its oligomerization"],"prefix":"10.1007","volume":"44","author":[{"given":"Zheng-Lan","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao-Sheng","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Ming","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Li","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,11]]},"reference":[{"key":"1354_CR1","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1182\/blood-2008-12-191254","volume":"113","author":"M Baccarani","year":"2009","unstructured":"Baccarani M, Rosti G, Castagnetti F et al (2009) Comparison of imatinib 400\u00a0mg and 800\u00a0mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study. Blood 113:4497\u20134504","journal-title":"Blood"},{"key":"1354_CR2","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1182\/blood-2003-03-0811","volume":"102","author":"T Beissert","year":"2003","unstructured":"Beissert T, Puccetti E, Bianchini A, Guller S, Boehrer S, Hoelzer D, Ottmann OG, Nervi C, Ruthardt M (2003) Targeting of the N-terminal coiled coil oligomerization interface of BCR interferes with the transformation potential of BCR-ABL and increases sensitivity to STI571. Blood 102:2985\u20132993","journal-title":"Blood"},{"key":"1354_CR3","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1002\/ijc.23467","volume":"122","author":"T Beissert","year":"2008","unstructured":"Beissert T, Hundertmark A, Kaburova V, Travaglini L, Mian AA, Nervi C, Ruthardt M (2008) Targeting of the N-terminal coiled coil oligomerization interface by a helix-2 peptide inhibits unmutated and imatinib-resistant BCR\/ABL. Int J Cancer 122:2744\u20132752","journal-title":"Int J Cancer"},{"key":"1354_CR4","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1200\/JCO.2007.15.8154","volume":"26","author":"H Lavallade de","year":"2008","unstructured":"de Lavallade H, Apperley JF, Khorashad JS, Milojkovic D, Reid AG, Bua M, Szydlo R, Olavarria E, Kaeda J, Goldman JM, Marin D (2008) Imatinib for Newly Diagnosed Patients With Chronic Myeloid Leukemia: incidence of Sustained Responses in an intention-to-treat analysis. J Clin Oncol 26:3358\u20133363","journal-title":"J Clin Oncol"},{"key":"1354_CR5","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","volume":"96","author":"MWN Deininger","year":"2000","unstructured":"Deininger MWN, Goldman JM, Melo JV (2000) The molecular biology of chronic myeloid leukemia. Blood 96:3343\u20133356","journal-title":"Blood"},{"key":"1354_CR6","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","volume":"105","author":"M Deininger","year":"2005","unstructured":"Deininger M, Buchdunger E, Druker BJ (2005) The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood 105:2640\u20132653","journal-title":"Blood"},{"key":"1354_CR7","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","volume":"355","author":"BJ Druker","year":"2006","unstructured":"Druker BJ, Guilhot F, O\u2019Brien SG et al (2006) Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 355:2408\u20132417","journal-title":"N Engl J Med"},{"key":"1354_CR8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199907153410306","volume":"341","author":"S Faderl","year":"1999","unstructured":"Faderl S, Talpaz M, Estrov Z, O\u2019Brien S, Kurzrock R, Kantarjian HM (1999) The biology of chronic myeloid leukemia. N Engl J Med 341:164\u2013172","journal-title":"N Engl J Med"},{"key":"1354_CR9","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0092-8674(88)90263-2","volume":"55","author":"AD Frankel","year":"1988","unstructured":"Frankel AD, Pabo CO (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55:1189\u20131193","journal-title":"Cell"},{"key":"1354_CR10","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/sj.leu.2403267","volume":"18","author":"Y Gao","year":"2004","unstructured":"Gao Y, Xiong D, Yang M et al (2004) Efficient inhibition of multidrug-resistant human tumors with a recombinant bispecific anti-P-glycoprotein [times] anti-CD3 diabody. Leukemia 18:513\u2013520","journal-title":"Leukemia"},{"key":"1354_CR11","doi-asserted-by":"crossref","first-page":"13186","DOI":"10.1073\/pnas.96.23.13186","volume":"96","author":"S Ghaffari","year":"1999","unstructured":"Ghaffari S, Wu H, Gerlach M, Han Y, Lodish HF, Daley GQ (1999) BCR-ABL and v-SRC tyrosine kinase oncoproteins support normal erythroid development in erythropoietin receptor-deficient progenitor cells. Proc Natl Acad Sci USA 96:13186\u201313190","journal-title":"Proc Natl Acad Sci USA"},{"key":"1354_CR12","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0092-8674(88)90262-0","volume":"55","author":"M Green","year":"1988","unstructured":"Green M, Loewenstein PM (1988) Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55:1179\u20131188","journal-title":"Cell"},{"key":"1354_CR13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/107327480901600202","volume":"16","author":"LA Hazlehurst","year":"2009","unstructured":"Hazlehurst LA, Bewry NN, Nair RR, Pinilla-Ibarz J (2009) Signaling networks associated with BCR-ABL\u2013Dependent transformation. Cancer Control 16:100\u2013107","journal-title":"Cancer Control"},{"key":"1354_CR14","doi-asserted-by":"crossref","first-page":"20805","DOI":"10.1073\/pnas.0706574105","volume":"104","author":"HD Herce","year":"2007","unstructured":"Herce HD, Garcia AE (2007) Molecular dynamics simulations suggest a mechanism for translocation of the HIV-1 TAT peptide across lipid membranes. Proc Natl Acad Sci 104:20805\u201320810","journal-title":"Proc Natl Acad Sci"},{"key":"1354_CR15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/1042819031000151905","volume":"45","author":"MS Holtz","year":"2004","unstructured":"Holtz MS, Bhatia R (2004) Effect of imatinib mesylate on chronic myelogenous leukemia hematopoietic progenitor cells. Leuk Lymphoma 45:237\u2013245","journal-title":"Leuk Lymphoma"},{"key":"1354_CR16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.biopha.2011.02.013","volume":"65","author":"Z Huang","year":"2011","unstructured":"Huang Z, Ji M, Peng Z, Huang S, Xiao Q, Li C, Zeng J, Gao M, Feng W (2011) Purification of TAT-CC-HA protein under native condition, and its transduction analysis and biological effects on BCR-ABL positive cells. Biomed Pharmacother 65:183\u2013192","journal-title":"Biomed Pharmacother"},{"key":"1354_CR17","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1182\/blood.V86.10.3897.bloodjournal86103897","volume":"86","author":"RJ Ilaria","year":"1995","unstructured":"Ilaria RJ, Van Etten R (1995) The SH2 domain of P210BCR\/ABL is not required for the transformation of hematopoietic factor-dependent cells. Blood 86:3897\u20133904","journal-title":"Blood"},{"key":"1354_CR18","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1182\/blood-2008-04-154344","volume":"113","author":"E Jabbour","year":"2009","unstructured":"Jabbour E, Kantarjian HM, Jones D et al (2009) Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy. Blood 113:2154\u20132160","journal-title":"Blood"},{"key":"1354_CR19","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.onc.1209119","volume":"25","author":"A Jacquel","year":"2005","unstructured":"Jacquel A, Herrant M, Defamie V et al (2005) A survey of the signaling pathways involved in megakaryocytic differentiation of the human K562 leukemia cell line by molecular and c-DNA array analysis. Oncogene 25:781\u2013794","journal-title":"Oncogene"},{"key":"1354_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/Y07-125","volume":"86","author":"MW Kinyanjui","year":"2008","unstructured":"Kinyanjui MW, Fixman ED (2008) Cell-penetrating peptides and proteins: new inhibitors of allergic airways disease. This review is an invited paper from 2007 ICRH Leadership in Science: a forum for trainees and new investigators. Can J Physiol Pharmacol 86:1\u20137","journal-title":"Can J Physiol Pharmacol"},{"key":"1354_CR21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ijc.2910180405","volume":"18","author":"E Klein","year":"1976","unstructured":"Klein E, V\u00e1nky F, Ben-Bassat H, Neumann H, Ralph P, Zeuthen J, Polliack A (1976) Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia. Int J Cancer 18:421\u2013431","journal-title":"Int J Cancer"},{"key":"1354_CR22","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.2408149","volume":"247","author":"T Lugo","year":"1990","unstructured":"Lugo T, Pendergast A, Muller A, Witte O (1990) Tyrosine kinase activity and transformation potency of BCR-ABL oncogene products. Science 247:1079\u20131082","journal-title":"Science"},{"key":"1354_CR23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0037-1963(03)70005-5","volume":"40","author":"S Martin","year":"2003","unstructured":"Martin S, James DG (2003) Molecular mechanisms of transformation by the BCR-ABL oncogene. Semin Hematol 40:4\u201310","journal-title":"Semin Hematol"},{"key":"1354_CR24","doi-asserted-by":"crossref","first-page":"7587","DOI":"10.1128\/MCB.13.12.7587","volume":"13","author":"JR McWhirter","year":"1993","unstructured":"McWhirter JR, Galasso DL, Wang JY (1993) A coiled-coil oligomerization domain of BCR is essential for the transforming function of BCR-ABL oncoproteins. Mol Cell Biol 13:7587\u20137595","journal-title":"Mol Cell Biol"},{"key":"1354_CR25","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.hoc.2004.03.008","volume":"18","author":"JV Melo","year":"2004","unstructured":"Melo JV, Deininger MW (2004) Biology of chronic myelogenous leukemia\u2013signaling pathways of initiation and transformation. Hematol Oncol Clin North Am 18:545\u2013568 (vii\u2013viii)","journal-title":"Hematol Oncol Clin North Am"},{"key":"1354_CR26","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1038\/leu.2009.194","volume":"23","author":"AA Mian","year":"2009","unstructured":"Mian AA, Oancea C, Zhao Z, Ottmann OG, Ruthardt M (2009) Oligomerization inhibition, combined with allosteric inhibition, abrogates the transformation potential of T315I-positive BCR\/ABL. Leukemia 23:2242\u20132247","journal-title":"Leukemia"},{"key":"1354_CR27","doi-asserted-by":"crossref","first-page":"22925","DOI":"10.1016\/S0021-9258(17)31596-X","volume":"269","author":"T Oda","year":"1994","unstructured":"Oda T, Heaney C, Hagopian JR, Okuda K, Griffin JD, Druker BJ (1994) Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia. J Biol Chem 269:22925\u201322928","journal-title":"J Biol Chem"},{"key":"1354_CR28","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3324\/haematol.12265","volume":"93","author":"F Palandri","year":"2008","unstructured":"Palandri F, Iacobucci I, Castagnetti F et al (2008) Front-line treatment of Philadelphia positive chronic myeloid leukemia with imatinib and interferon-{alpha}: 5-year outcome. Haematologica 93:770\u2013774","journal-title":"Haematologica"},{"key":"1354_CR29","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1517\/17425240902887029","volume":"6","author":"M Rapoport","year":"2009","unstructured":"Rapoport M, Lorberboum-Galski H (2009) TAT-based drug delivery system\u2014new directions in protein delivery for new hopes? Expert Opin Drug Deliv 6:453\u2013463","journal-title":"Expert Opin Drug Deliv"},{"key":"1354_CR30","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1074\/jbc.M209548200","volume":"278","author":"JP Richard","year":"2003","unstructured":"Richard JP, Melikov K, Vives E, Ramos C, Verbeure B, Gait MJ, Chernomordik LV, Lebleu B (2003) Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem 278:585\u2013590","journal-title":"J Biol Chem"},{"key":"1354_CR31","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.ceb.2010.07.014","volume":"22","author":"SG Rolland","year":"2010","unstructured":"Rolland SG, Conradt B (2010) New role of the BCL2 family of proteins in the regulation of mitochondrial dynamics. Curr Opin Cell Biol 22:852\u2013858","journal-title":"Curr Opin Cell Biol"},{"key":"1354_CR32","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.leu.2401010","volume":"12","author":"M Sattler","year":"1998","unstructured":"Sattler M, Salgia R (1998) Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR\/ABL-transformed cells. Leukemia 12:637\u2013644","journal-title":"Leukemia"},{"key":"1354_CR33","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1158\/0008-5472.CAN-09-0899","volume":"69","author":"AG Schroering","year":"2009","unstructured":"Schroering AG, Kothandapani A, Patrick SM, Kaliyaperumal S, Sharma VP, Williams KJ (2009) Prolonged cell cycle response of HeLa cells to low-level alkylation exposure. Cancer Res 69:6307\u20136314","journal-title":"Cancer Res"},{"key":"1354_CR34","first-page":"247","volume":"13","author":"K Shuai","year":"1996","unstructured":"Shuai K, Halpern J, ten Hoeve J, Rao X, Sawyers C (1996) Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. Oncogene 13:247\u2013254","journal-title":"Oncogene"},{"key":"1354_CR35","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1515\/pm-1993-301002","volume":"30","author":"A Strecker","year":"1993","unstructured":"Strecker A, Salzberger U, Mayer J (1993) Specimen preparation for transmission electron microscopy (TEM)\u2013reliable method for cross sections and brittle materials. Prakt Metallogr 30:482\u2013495","journal-title":"Prakt Metallogr"},{"key":"1354_CR36","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1158\/0008-5472.SABCS-09-2106","volume":"69","author":"E Tzoracoleftherakis","year":"2010","unstructured":"Tzoracoleftherakis E, Sdralis E, Maroulis J, Ravazoula P (2010) Radiofrequency ablation in breast cancer. Cancer Res 69:2106","journal-title":"Cancer Res"},{"key":"1354_CR37","doi-asserted-by":"crossref","first-page":"16010","DOI":"10.1074\/jbc.272.25.16010","volume":"272","author":"E Vive`s","year":"1997","unstructured":"Vive`s E, Brodin P, Lebleu B (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 272:16010\u201316017","journal-title":"J Biol Chem"},{"key":"1354_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2008.06.003","volume":"274","author":"G Volpe","year":"2009","unstructured":"Volpe G, Panuzzo C, Ulisciani S, Cilloni D (2009) Imatinib resistance in CML. Cancer Lett 274:1\u20139","journal-title":"Cancer Lett"},{"key":"1354_CR39","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/MCB.21.3.840-853.2001","volume":"21","author":"X Zhang","year":"2001","unstructured":"Zhang X, Subrahmanyam R, Wong R, Gross AW, Ren R (2001) The NH2-terminal coiled-coil domain and tyrosine 177 play important roles in induction of a myeloproliferative disease in mice by BCR-ABL. Mol Cell Biol 21:840\u2013853","journal-title":"Mol Cell Biol"},{"key":"1354_CR40","first-page":"117","volume":"9","author":"X Zhao","year":"2002","unstructured":"Zhao X, Ghaffari S, Lodish H, Malashkevich VN, Kim PS (2002) Structure of the BCR-ABL oncoprotein oligomerization domain. Nat Struct Mol Biol 9:117\u2013120","journal-title":"Nat Struct Mol Biol"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-012-1354-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00726-012-1354-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-012-1354-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T19:44:34Z","timestamp":1642707874000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00726-012-1354-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,11]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["1354"],"URL":"https:\/\/doi.org\/10.1007\/s00726-012-1354-3","relation":{},"ISSN":["0939-4451","1438-2199"],"issn-type":[{"value":"0939-4451","type":"print"},{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,11]]}}}